▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for (ALIOF) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $278.50.
The current consensus among 0 contributing investment analysts is to n/a stock in (ALIOF). This N/A consensus rating has held steady for over two years.
Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.